IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 401 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $71,000 | -64.9% | 1,200 | -71.9% | 0.01% | -70.8% |
| Q1 2020 | $202,000 | -21.7% | 4,267 | 0.0% | 0.02% | 0.0% |
| Q4 2019 | $258,000 | +5.7% | 4,267 | +4.9% | 0.02% | -4.0% |
| Q3 2019 | $244,000 | -6.5% | 4,067 | 0.0% | 0.02% | -3.8% |
| Q2 2019 | $261,000 | -22.6% | 4,067 | -2.1% | 0.03% | -29.7% |
| Q1 2019 | $337,000 | – | 4,155 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |